Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Due to the current situation in Israel some orders may be delayed

 

How does Briviact compare to Keppra and other epilepsy medications for seizure control?

Briviact works similarly to Keppra by targeting a protein involved in seizure activity, but it may cause fewer behavioral side effects and is often reserved for patients who do not respond well to other treatments.

Overview

People managing epilepsy often ask how Briviact compares to other seizure medications like Keppra. Both are used for focal (partial-onset) seizures but differ in tolerability and individual response.

  • Briviact and Keppra target similar brain receptors but have slightly different chemical structures.
  • Some patients may tolerate Briviact better, especially regarding mood and behavior.
  • This article briefly reviews how Briviact functions, its clinical uses, safety, and where to get it.

Understanding these differences helps patients and doctors make informed treatment decisions.

Detailed Information

How it works

Briviact may work by modifying the function of synaptic vesicle protein 2A, a target also shared by Keppra. This protein helps regulate seizure activity in the brain. Although the exact action is not fully understood, Briviact’s more selective binding could potentially reduce some side effects seen with similar drugs.

Clinical applications

According to approved information, Briviact is used as an add-on therapy for partial-onset seizures in patients aged 4 years and older. It is often chosen for individuals who have not responded well to medications like Keppra or who experience intolerable side effects from other antiepileptics.

This helps explain why some neurologists switch patients to Briviact when other treatments fall short.

Safety and Effectiveness

Safety profile

According to Drugs.com, Briviact may cause common side effects like drowsiness, dizziness, nausea, and fatigue. Serious behavioral effects such as irritability or aggression occur less frequently than with Keppra in some patients, but caution is still advised. Always consult your healthcare provider before switching medications.

FDA approval and indications

Briviact is FDA-approved for the treatment of partial-onset seizures. It is indicated as either monotherapy in adults or as an add-on in patients age 4 and above. These approvals are based on clinical guidelines set by regulatory authorities.

Safe use requires proper dosing and close monitoring by a physician familiar with seizure treatment protocols.

Access and Availability

How to obtain safely

A licensed online pharmacy like IsraelPharm offers access to Briviact for international patients. They provide regulated medications at competitive prices with verified authenticity. Always consult your healthcare provider to confirm it’s the right fit for your treatment plan.

Key Takeaways

  • Briviact shares a similar target with Keppra but may be better tolerated in some patients.
  • It is approved for use in both children and adults with focal seizures.
  • Briviact may be a suitable alternative when other seizure meds cause behavioral issues.
  • Careful monitoring by a healthcare provider is essential when starting or switching antiepileptic drugs.
  • You can purchase Briviact from reputable sources like IsraelPharm under proper medical guidance.

FAQ

What makes Briviact different from Keppra?

While both medications target the same brain protein (SV2A), Briviact binds more selectively, which may lead to fewer behavioral side effects for some users. Individual experiences, however, vary.

Is Briviact effective if Keppra didn’t work?

Briviact may help some individuals who didn’t respond well to Keppra, particularly those who experienced mood-related side effects. Treatment success should still be regularly assessed by a neurologist.

Who is a good candidate for Briviact?

Patients with partial-onset seizures who can’t tolerate Keppra or whose seizures are not well-controlled may be considered for Briviact. A neurologist can help determine suitability.

Can children use Briviact?

Yes, Briviact is approved for children aged 4 and older for the treatment of focal (partial-onset) seizures, as confirmed in the patient information leaflet. Dosage may differ based on age and weight.

Where can I buy Briviact if I live outside the U.S.?

International patients can access epilepsy medications like Briviact. Always purchase through licensed pharmacies and under your doctor’s guidance.

 

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email